Objective: To evaluate the efficacy and tolerability of amoxicillin/clavulanic (AMX/CLV) acid as treatment for cutaneous actinomycosis.
Methods: We present a long-term follow-up study of cutaneous actinomycosis patients. Cervicofacial (CFA) and abdominal (AA) were recruited during 6 years.
Indian J Dermatol Venereol Leprol
May 2010
Indian J Dermatol Venereol Leprol
August 2009